Minerva Surgical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	51.69	50.29	52.1	37.77	26.01
Revenue Growth (YoY)	3.11%	-3.47%	37.96%	45.19%	-
Cost of Revenue	23.69	23.05	21.58	18.65	14.21
Gross Profit	28.01	27.24	30.52	19.12	11.81
Selling, General & Admin	51.15	52.7	54.38	31.19	30.51
Research & Development	6.11	5.44	5.29	3.32	0.94
Other Operating Expenses	-0.04	-0.07	-0.34	0.07	0.17
Operating Expenses	57.26	58.14	59.67	34.51	31.44
Operating Income	-29.26	-30.9	-29.15	-15.39	-19.64
Interest Income	0.3	0.09	0.01	0.08	0.14
Interest Expense	2.05	3.22	11.73	12.14	17.58
Other Expense / Income	2.39	0.07	-19.41	-9.05	14.97
Pretax Income	-33.4	-34.1	-21.46	-18.4	-52.05
Income Tax	2.15	0.01	0.01	-0.13	17.75
Net Income	-35.55	-34.11	-21.46	-18.26	-69.8
Shares Outstanding (Basic)	9	1	0	1	1
Shares Outstanding (Diluted)	9	1	0	1	1
Shares Change	520.25%	310.83%	-65.62%	10.02%	-
EPS (Basic)	-4.81	-23.68	-61.22	-17.91	-75.29
EPS (Diluted)	-4.81	-23.68	-61.22	-17.91	-75.29
Free Cash Flow	-38.8	-35.64	-22.96	-12.69	-20.02
Free Cash Flow Per Share	-4.37	-24.74	-65.49	-12.45	-21.59
Gross Margin	54.18%	54.17%	58.58%	50.62%	45.38%
Operating Margin	-56.60%	-61.44%	-55.94%	-40.75%	-75.49%
Profit Margin	-68.77%	-67.83%	-41.20%	-48.36%	-268.32%
Free Cash Flow Margin	-75.06%	-70.86%	-44.07%	-33.61%	-76.95%
EBITDA	-27.11	-30.88	-18.86	-8.16	-17.66
EBITDA Margin	-52.44%	-61.40%	-36.19%	-21.61%	-67.88%
Depreciation & Amortization	8.7	10.81	10.62	7.08	1.68
EBIT	-35.81	-41.69	-29.48	-15.24	-19.33
EBIT Margin	-69.26%	-82.88%	-56.57%	-40.35%	-74.32%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.